LightForce
44 3rd Ave, Burlington, Massachusetts, 01803, United States
Overview
LightForce develops the world’s first fully personalized 3D-printed braces system and specializes in 3D-printed dental brackets for orthodontists. The company offers a comprehensive braces solution intended to improve treatment efficiency and clinical aesthetics. LightForce uses AI to generate accurate digital representations of patient anatomy and optimal tooth positions. Its product aims to enable orthodontists to provide personalized solutions for individual patients. The company announced a $50 million growth-capital commitment to support continued expansion. Leadership says the financing will help drive growth and broaden access to personalized braces solutions. LightForce offers a comprehensive braces solution centered on fully personalized, 3D‑printed brackets manufactured to a digital treatment plan and supported by end-to-end software. Its platform spans intraoral and CBCT support through to final prescription and incorporates AI to generate accurate digital representations of patient anatomy and optimal tooth positions. A peer‑reviewed Journal of Clinical Orthodontics study cited in the articles found LightForce cases finished 45% faster with 41% fewer scheduled appointments than conventional bracket cases. The company plans to scale production with a new 36,000‑square‑foot manufacturing facility in Wilmington, Massachusetts, and to expand its engineering and scientific teams. LightForce will also invest the new capital to advance AI in its workflows and to build clinical education resources to help orthodontists adopt fully digital, personalized treatments. The company launched commercial operations in 2020 and is positioning its technology to shorten treatment times and improve patient outcomes while shifting the industry away from one‑size‑fits‑all braces.
- Total raised
- $194M
- Funding rounds
- 4
- Latest round
- Equity
- Latest activity
- Sep 2024
Industries
- 3D Technology
- Dental
- Health Care
- Medical
- Software
Recent funding
Equity
Sep 2024
$50M
Series D
Aug 2023
$80M
Series C
Nov 2021
$50M
Series B
Sep 2020
$14M